TapewireFind a company

person · Reporting owner

Alger Jason

Disclosed activity across 1 company

Tapewire entity
2144
SEC CIK
0001839111

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Health Catalyst, Inc.HCAT · Entity 1565Chief Financial OfficerSeptember 01, 2026September 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Health Catalyst, Inc.

Report date September 01, 2026 · Filed September 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect704,867 Reported balance After 2026-09-01 transaction · row 1
1 source row

Row 1 · 2026-09-01 · Tax withholding · Disposed 17,973 · Balance 704,867

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2026 Filed Sep 3, 2026 21:11 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 17,973 $1.70 $30,618.80
Disclosure

SEC source: 0001839111-26-000004 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 704,867

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 23:45 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 18,804 $1.37 $25,765.24
Disclosure

SEC source: 0001839111-26-000003 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 722,840

F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 23:48 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 26,970 $1.66 $44,767.50
Disclosure

SEC source: 0001839111-26-000002 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 741,644

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 26, 2026 Filed Feb 27, 2026 21:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 7,522 $1.75 $13,146.95
Disclosure

SEC source: 0001839111-26-000001 · primarydocument.xml · nonDerivative · entry 3

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 768,614

F3 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 22,222 $0.00 $0.00
Disclosure

SEC source: 0001839111-26-000001 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 776,136

F2 · shares: Represents an award of 22,222 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 507,500 $0.00 $0.00
Disclosure

SEC source: 0001839111-26-000001 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 753,914

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 21:19 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 20,619 $2.90 $59,799.22
Disclosure

SEC source: 0001839111-25-000002 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,414

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 02, 2025 Filed Sep 4, 2025 22:33 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 2,613 $3.36 $8,786.74
Disclosure

SEC source: 0001562180-25-006103 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,033

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 01:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 2,712 $3.63 $9,857.58
Disclosure

SEC source: 0001562180-25-004391 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,646

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 22:21 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 7,304 $4.58 $33,431.14
Disclosure

SEC source: 0001562180-25-002007 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,358

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 01:49 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 11,950 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-001550 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,662

F2 · shares: Represents an award of 11,950 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
February 20, 2025 Filed Feb 25, 2025 01:49 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 181,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-25-001550 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,712

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 19,599 $8.32 $163,049.96
Disclosure

SEC source: 0001562180-24-008307 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,712

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 13th, 2024, in accordance with Rule 10b5-1.

Read SEC document
December 01, 2024 Filed Dec 3, 2024 21:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 7,795 $8.97 $69,946.09
Disclosure

SEC source: 0001562180-24-008098 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,311

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 06, 2024 Filed Sep 10, 2024 22:05 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,899 $7.39 $21,426.80
Disclosure

SEC source: 0001562180-24-006758 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,106

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 13th, 2024, in accordance with Rule 10b5-1.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 20:41 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,165 $7.27 $8,468.50
Disclosure

SEC source: 0001562180-24-006683 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,005

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:17 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,823 $6.83 $19,281.09
Disclosure

SEC source: 0001562180-24-005059 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 118,170

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 13th, 2024, in accordance with Rule 10b5-1.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,238 $6.53 $8,088.23
Disclosure

SEC source: 0001562180-24-004629 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,993

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 70,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-002256 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 122,231

F2 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 21:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 2,474 $8.05 $19,918.67
Disclosure

SEC source: 0001562180-24-002256 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,231

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 00:34 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 2,778 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-001653 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,705

F1 · shares: Represents an award of 2,778 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 06, 2023 Filed Dec 7, 2023 23:29 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,177 $7.55 $16,436.35
Disclosure

SEC source: 0001562180-23-008212 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 51,927

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2022 in accordance with Rule 10b5-1.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 22:39 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 2,838 $7.45 $21,143.95
Disclosure

SEC source: 0001562180-23-008136 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,104

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 06, 2023 Filed Sep 7, 2023 00:47 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,197 $11.65 $25,596.59
Disclosure

SEC source: 0001562180-23-006763 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,942

F2 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2022 in accordance with Rule 10b5-1.

Read SEC document
September 01, 2023 Filed Sep 7, 2023 00:47 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 929 $11.78 $10,940.37
Disclosure

SEC source: 0001562180-23-006763 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,139

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:26 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,370 $11.84 $28,060.80
Disclosure

SEC source: 0001562180-23-004993 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,068

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2022 in accordance with Rule 10b5-1.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 23:31 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,066 $11.24 $11,980.77
Disclosure

SEC source: 0001562180-23-004858 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,438

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 8,181 shares held by the Reporting Person that were not previously reported due to an inadvertent administrative error.

Read SEC document
March 03, 2023 Filed Mar 7, 2023 21:30 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 2,967 $14.23 $42,229.31
Disclosure

SEC source: 0001562180-23-002571 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,323

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:09 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 1,142 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-002428 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,290

F2 · shares: Represents an award of 1,142 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2022, the PRSUs noted above vested on March 1, 2023.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 22:09 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,614 $14.29 $23,061.80
Disclosure

SEC source: 0001562180-23-002428 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,148

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
February 22, 2023 Filed Feb 24, 2023 21:10 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-001829 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,762

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Read SEC document
December 06, 2022 Filed Dec 8, 2022 21:50 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 259 $10.39 $2,691.29
Disclosure

SEC source: 0001562180-22-008170 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,762

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
December 01, 2022 Filed Dec 5, 2022 21:38 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 2,501 $10.65 $26,634.90
Disclosure

SEC source: 0001562180-22-008054 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,021

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 06, 2022 Filed Sep 8, 2022 20:04 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 262 $11.28 $2,955.39
Disclosure

SEC source: 0001562180-22-006555 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,522

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
September 01, 2022 Filed Sep 6, 2022 20:11 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 567 $11.61 $6,580.04
Disclosure

SEC source: 0001562180-22-006496 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,784

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:02 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 261 $14.95 $3,902.39
Disclosure

SEC source: 0001562180-22-004907 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,351

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:47 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 20 $14.95 $299.04
Disclosure

SEC source: 0001562180-22-004819 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,612

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F3 · price: Represents the weighted average sale price of the shares sold ranging from $14.91 to $15.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).

Read SEC document
June 01, 2022 Filed Jun 3, 2022 21:47 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 547 $14.24 $7,787.69
Disclosure

SEC source: 0001562180-22-004819 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,632

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $13.91 to $14.90 per share, inclusive.

Read SEC document
March 07, 2022 Filed Mar 9, 2022 22:29 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 461 $25.14 $11,589.54
Disclosure

SEC source: 0001562180-22-002488 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,179

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 00:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 157 $26.69 $4,190.53
Disclosure

SEC source: 0001562180-22-002341 · primarydocument.xml · nonDerivative · entry 3

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,640

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F4 · price: Represents the weighted average sale price of the shares sold ranging from $25.29 to $27.56 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (4).

Read SEC document
March 01, 2022 Filed Mar 4, 2022 00:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 1,551 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002341 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,797

F3 · shares: Represents an award of 1,551 performance-based restricted units ("PRSUs") pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan and Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2021, the PRSUs noted above vested on March 1, 2022.

Read SEC document
March 01, 2022 Filed Mar 4, 2022 00:36 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 962 $26.63 $25,618.73
Disclosure

SEC source: 0001562180-22-002341 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,246

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents the weighted average sale price of the shares sold ranging from $26.23 to $27.44 per share, inclusive.

Read SEC document
February 24, 2022 Filed Mar 1, 2022 02:25 UTC Health Catalyst, Inc. HCAT · Entity 1565 GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-22-002022 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,208

F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2022 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments.

Read SEC document
December 06, 2021 Filed Dec 7, 2021 21:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 644 $38.83 $25,006.52
Disclosure

SEC source: 0001562180-21-007534 · primarydocument.xml · nonDerivative · entry 2

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,208

F3 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 15, 2020, in accordance with Rule 10b5-1.

Read SEC document
December 02, 2021 Filed Dec 7, 2021 21:14 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 1,460 $41.95 $61,243.35
Disclosure

SEC source: 0001562180-21-007534 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,852

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.

Read SEC document
September 03, 2021 Filed Sep 8, 2021 20:08 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 652 $54.23 $35,357.96
Disclosure

SEC source: 0001562180-21-005874 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,312

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December, 15 2020, in accordance with Rule 10b5-1.

Read SEC document
September 01, 2021 Filed Sep 3, 2021 20:07 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 286 $54.23 $15,510.38
Disclosure

SEC source: 0001562180-21-005802 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,964

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.91 to $54.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document
June 03, 2021 Filed Jun 8, 2021 00:23 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 665 $52.75 $35,081.28
Disclosure

SEC source: 0001562180-21-004107 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,250

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December, 15 2020, in accordance with Rule 10b5-1.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.51 to $52.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 23:35 UTC Health Catalyst, Inc. HCAT · Entity 1565 Tax withholdingCommon Stock 272 $53.88 $14,654.19
Disclosure

SEC source: 0001562180-21-004061 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,915

F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $53.66 to $54.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document
April 13, 2021 Filed Apr 15, 2021 23:56 UTC Health Catalyst, Inc. HCAT · Entity 1565 SaleCommon Stock 6,301 $50.07 $315,465.24
Disclosure

SEC source: 0001562180-21-002838 · primarydocument.xml · nonDerivative · entry 1

Alger Jason · CIK 0001839111 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,187

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December, 15 2020, in accordance with Rule 10b5-1.

F2 · price: Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $50.00 to $50.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.